A Study Designed to Compare 2 Dose Strengths of TI Inhalation Powder in Adults With Type 1 Diabetes Mellitus and to Compare One of Those Formulations (30Units) With an Injection of Insulin Lispro

NCT00662857 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus: Type 1

Interventions

DRUG: Technosphere® Insulin Inhalation Powder
DRUG: Technosphere Insulin® Inhalation Powder
DRUG: RAA Population

Sponsor

Mannkind Corporation